HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Gynaecological cancers encompass a range of malignancies that affect the female reproductive system, each with its unique characteristics, risk factors, and treatment approaches. Cervical cancer, closely linked to persistent human papillomavirus (HPV) infection, primarily arises in the cervix. Regular screenings, such as Pap smears, and HPV vaccinations are pivotal for early detection and prevention. Treatment modalities for cervical cancer may involve surgery, radiation, or chemotherapy, depending on the stage of the disease.
Ovarian cancer, originating in the ovaries, poses challenges in early detection, often leading to diagnosis in advanced stages. Treatment typically involves a combination of surgery and chemotherapy, with ongoing research exploring targeted therapies for improved outcomes. Uterine (endometrial) cancer, affecting the lining of the uterus, is associated with hormonal imbalances and obesity. Recognizing symptoms like abnormal vaginal bleeding facilitates early detection, and treatment options may include surgery, radiation, or hormonal therapy.
Fallopian tube cancer, though rare, requires attention to surgical interventions, and in some cases, chemotherapy may be recommended. Vulvar cancer, affecting the external genitalia, has risk factors such as age, chronic skin conditions, and HPV infection. Treatment involves surgical procedures, potentially complemented by radiation or chemotherapy. Early detection, regular screenings, and awareness of risk factors play pivotal roles in managing gynaecological cancers. Ongoing research strives to enhance prevention strategies, refine treatment protocols, and improve the overall well-being of women facing these complex health challenges.
